価格表

在庫・価格 : 2024年06月08日 09時22分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Flk-1, Human, Goat-Poly <Anti-VEGF Receptor 2>
データシート※最新のデータシートでない場合があります
AF357 RSDアールアンドディー システムス
R&D Systems, Inc.
100 μg ¥106,000
(未発注)
追加

在庫・価格 : 2024年06月08日 09時22分 現在

Anti-Flk-1, Human, Goat-Poly <Anti-VEGF Receptor 2>

  • 商品コード:AF357
  • メーカー:RSD
  • 包装:100μg
  • 価格: ¥106,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Liu C et al. Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects.
Liu C et al
2001/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
2 Rissanen TT et al. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am. J. Pathol. 2002 Apr;160(4):1393-403
Rissanen TT et al
2002/01/01
Species: Human, Rabbit, Application: IHC Paraffin-embedded, Sample type: Whole Tissue PubMed
3 Masood R et al. Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. Int. J. Cancer 2003 May;104(5):603-10
Masood R et al
2003/01/01
Application: IHC Fresh/Frozen,Western Blot, Sample Type: Cell Lysates,Whole Cells PubMed
4 Giuliani N et al. Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis. Blood 2003 Jul;102(2):638-45
Giuliani N et al
2003/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
5 De S et al. Molecular pathway for cancer metastasis to bone. J. Biol. Chem. 2003 Oct;278(40):39044-50
De S et al
2003/01/01
human LNCaP, LNCaP-C4 2, PC3, and CWR22Rv1-H prostate cancer cell lines PubMed
6 Kanda S et al. Fibroblast growth factor-2-mediated capillary morphogenesis of endothelial cells requires signals via Flt-1/vascular endothelial growth factor receptor-1: possible involvement of c-Akt. J. Biol. Chem. 2004 Feb;279(6):4007-16
Kanda S et al
2004/01/01
human umbilical vein endothelial cells and porcine aortic endothelial cells expressing human VEGF R2/KDR PubMed
7 Usui T et al. VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. Invest. Ophthalmol. Vis. Sci. 2004 Feb;45(2):368-74
Usui T et al
2004/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
8 Steiner H et al. An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6. Eur. J. Cancer 2004 May;40(7):1066-72
Steiner H et al
2004/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
9 Eichler W et al. PEDF derived from glial Mテθ津つシller cells: a possible regulator of retinal angiogenesis. Exp. Cell Res. 2004 Sep;299(1):68-78
Eichler W et al
2004/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
10 Szukiewicz D et al. Mast cell-derived VEGF and VEGF receptor type 1, 2, and 3 expression in human term trophoblast culture--influence of hypoxia. Inflamm. Res. 2005 Apr;54 Suppl 1:S82-3
Szukiewicz D et al
2005/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
11 Asikainen TM et al. Activation of hypoxia-inducible factors in hyperoxia through prolyl 4-hydroxylase blockade in cells and explants of primate lung. Proc. Natl. Acad. Sci. U.S.A. 2005 Jul;102(29):10212-7
Asikainen TM et al
2005/01/01
Application: IHC Fresh,Neutralization, Sample Type: Whole Cells PubMed
12 Garton AJ et al. OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models. Cancer Res. 2006 Jan;66(2):1015-24
Garton AJ et al
2006/01/01
Application: Immunoprecipitation, Sample Type: Cell Lysates PubMed
13 Roberts N et al. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res. 2006 Mar;66(5):2650-7
Roberts N et al
2006/01/01
mouse tumor metastasis, lymph node, and lung PubMed
14 Pyakurel P et al. Lymphatic and vascular origin of Kaposi&quot;s sarcoma spindle cells during tumor development. Int. J. Cancer 2006 Sep;119(6):1262-7
Pyakurel P et al
2006/01/01
Species: Human, Application: IHC Paraffin-embedded, Whole Tissue PubMed
15 Albert DH et al. Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor. Mol. Cancer Ther. 2006 Apr;5(4):995-1006
Albert DH et al
2006/01/01
Application: Immunoprecipitation, Sample Type: Cell Lysates,Homogenized Tissue PubMed
16 Asikainen TM et al. Enhancement of angiogenic effectors through hypoxia-inducible factor in preterm primate lung in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 2006 Oct;291(4):L588-95
Asikainen TM et al
2006/01/01
Species: Primate - Baboon, Application: Western Blot, Homogenized Tissue PubMed
17 Cianfarani F et al. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am. J. Pathol. 2006 Oct;169(4):1167-82
Cianfarani F et al
2006/01/01
Species: Human, Application: Neutralization, Western Blot, Sample type: Whole Cells, Cell Lysates PubMed
18 Argaw AT et al. IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J. Immunol. 2006 Oct;177(8):5574-84
Argaw AT et al
2006/01/01
Species: Human, Application: IHC Paraffin-embedded, Sample type: Whole Tissue PubMed
19 Ferrari G et al. VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc. Natl. Acad. Sci. U.S.A. 2006 Nov;103(46):17260-5
Ferrari G et al
2006/01/01
Species: Human, Application: Western Blot, Sample type: Cell Lysates PubMed
20 Goldman J et al. Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis. FASEB J. 2007 Apr;21(4):1003-12
Goldman J et al
2007/01/01
Application: Immunoprecipitation, Sample Type: Cell Lysates PubMed
21 Hashimoto A et al. Analysis of vascular gene expression in arthritic synovium by laser-mediated microdissection. Arthritis Rheum. 2007 Apr;56(4):1094-105
Hashimoto A et al
2007/01/01
Species: Human, Application: IHC Frozen, Sample type: Whole Tissue PubMed
22 Werner C et al. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. Diabetes 2007 Oct;56(10):2609-15
Werner C et al
2007/01/01
Species: Human, Application: Flow Cytometry, Sample type: Whole Cells PubMed
23 Osol G et al. Placental growth factor is a potent vasodilator of rat and human resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 2008 Mar;294(3):H1381-7
Osol G et al
2008/01/01
Species: Rat, Application: Neutralization, Whole Tissue PubMed
24 Mellberg S et al. Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis. FASEB J. 2009 May;23(5):1490-502
Mellberg S et al
2009/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
25 Mittar S et al. VEGFR1 receptor tyrosine kinase localization to the Golgi apparatus is calcium-dependent. Exp. Cell Res. 2009 Mar;315(5):877-89
Mittar S et al
2009/01/01
Application: Immunoprecipitation, Sample Type: Cell Lysates PubMed
26 Collino F et al. Epithelial-mesenchymal transition of ovarian tumor cells induces an angiogenic monocyte cell population. Exp. Cell Res. 2009 Oct;315(17):2982-94
Collino F et al
2009/01/01
Application: IHC Paraffin-embedded, Sample Type: Whole Tissue PubMed
27 Ardi VC et al. Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway. J. Biol. Chem. 2009 Sep;284(38):25854-66
Ardi VC et al
2009/01/01
Application: Neutralization, Sample Type: collagen onplants PubMed
28 Minami T et al. The Down syndrome critical region gene 1 short variant promoters direct vascular bed-specific gene expression during inflammation in mice. J. Clin. Invest. 2009 Aug;119(8):2257-70
Minami T et al
2009/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
29 Albuquerque RJ et al. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat. Med. 2009 Sep;15(9):1023-30
Albuquerque RJ et al
2009/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
30 Lee HS et al. Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis. Am. J. Respir. Crit. Care Med. 2009 Dec;180(11):1056-67
Lee HS et al
2009/01/01
Application: IHC Fresh/Frozen, Sample Type: Whole Tissue PubMed
31 Lepp辰nen VM et al. Structural determinants of vascular endothelial growth factor-D receptor binding and specificity. Blood 2011 Feb;117(5):1507-15
Lepp辰nen VM et al
2011/01/01
Application: Immunoprecipitation, Sample Type: Cell Lysates PubMed
32 Munaut C et al. Differential expression of Vegfr-2 and its soluble form in preeclampsia. PLoS ONE 2012;7(3):e33475
Munaut C et al
2012/01/01
Application: IHC Paraffin-embedded,Western Blot, Sample Type: Plasma,Whole Tissue PubMed
33 Gourlaouen M et al. Essential role for endocytosis in the growth factor-stimulated activation of ERK1/2 in endothelial cells. J. Biol. Chem. 2013 Mar;288(11):7467-80
Gourlaouen M et al
2013/01/01
Application: Bioassay, Sample Type: cell cultures PubMed
34 Goldman O et al. KDR identifies a conserved human and murine hepatic progenitor and instructs early liver development. Cell Stem Cell 2013 Jun;12(6):748-60
Goldman O et al
2013/01/01
Application: IHC Fresh, Sample Type: Whole Cells PubMed
35 Kasza Z et al. MicroRNA-24 suppression of N-deacetylase/N-sulfotransferase-1 (NDST1) reduces endothelial cell responsiveness to vascular endothelial growth factor A (VEGFA). J. Biol. Chem. 2013 Sep;288(36):25956-63
Kasza Z et al
2013/01/01
Application: Western Blot, Sample Type: Cell Lysates PubMed
36 Orecchia A et al. Endothelial cell adhesion to soluble vascular endothelial growth factor receptor-1 triggers a cell dynamic and angiogenic phenotype. FASEB J. 2014 Feb;28(2):692-704
Orecchia A et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
37 Etulain J et al. Control of angiogenesis by galectins involves the release of platelet-derived proangiogenic factors. PLoS ONE 2014;9(4):e96402
Etulain J et al
2014/01/01
Application: Blocking, Sample Type: Whole Cells PubMed
38 Fearnley GW et al. VEGF-A isoforms differentially regulate ATF-2-dependent VCAM-1 gene expression and endothelial-leukocyte interactions. Mol. Biol. Cell 2014 Aug;25(16):2509-21
Fearnley GW et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
39 Fiorio Pla A et al. Differential sensitivity of prostate tumor derived endothelial cells to sorafenib and sunitinib. BMC Cancer 2014;14:939
Fiorio Pla A et al
2014/01/01
Application: Western Blot, Sample Type: Cell Lysate PubMed
40 Shvartsman D et al. Sustained delivery of VEGF maintains innervation and promotes reperfusion in ischemic skeletal muscles via NGF/GDNF signaling. Mol. Ther. 2014 Jul;22(7):1243-53
Shvartsman D et al
2014/01/01
Application: Functional Assay, Sample Type: Whole Cells PubMed
41 Basagiannis D et al. VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation through macropinocytosis. J. Cell. Sci. 2016 Nov;129(21):4091-4104
Basagiannis D et al
2016/01/01
Application: Neutralization, Sample Type: Whole Cells PubMed
42 Tiede C et al. Affimer proteins are versatile and renewable affinity reagents. Elife 2017 06;6
Tiede C et al
2017/01/01
Species: Human, Applications: WB PubMed
43 Jin Y et al. Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling. Nat. Cell Biol. 2017 Jun;19(6):639-652
Jin Y et al
2017/01/01
Species: Mouse, Applications: IHC PubMed
44 Heinolainen K et al. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling. Circ. Res. 2017 Apr;120(9):1414-1425
Heinolainen K et al
2017/01/01
PubMed
45 Volk-Draper LD et al. Lymphatic endothelial progenitors originate from plastic myeloid cells activated by toll-like receptor-4. PLoS ONE 2017;12(6):e0179257
Volk-Draper LD et al
2017/01/01
PubMed
46 Veschi V et al. Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant. Oncogene 2020 01;39(5):987-1003
Veschi V et al
2020/01/01
PubMed
47 Genet G et al. Endophilin-A2 dependent VEGFR2 endocytosis promotes sprouting angiogenesis. Nat Commun 2019 05;10(1):2350
Genet G et al
2019/01/01
PubMed
48 Fearnley GW et al. ATF-2 and Tpl2 regulation of endothelial cell cycle progression and apoptosis. Cell Signal 2020 02;66:109481
Fearnley GW et al
2020/01/01
PubMed
49 Dallinga MG et al. The Role of Heparan Sulfate and Neuropilin 2 in VEGFA Signaling in Human Endothelial Tip Cells and Non-Tip Cells during Angiogenesis In Vitro. Cells 2021 Apr;10(4)
Dallinga MG et al
2021/01/01
Species: Human, Applications: ICC PubMed
50 Wei ST et al. Atypical chemokine receptor ACKR3/CXCR7 controls postnatal vasculogenesis and arterial specification by mesenchymal stem cells via Notch signaling. Cell Death Dis 2020 May;11(5):307
Wei ST et al
2020/01/01
Species: Human, Applications: Western Blot PubMed
  • No.: 1
  • 文献情報:
    Liu C et al. Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects.
    Liu C et al
    2001/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Rissanen TT et al. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am. J. Pathol. 2002 Apr;160(4):1393-403
    Rissanen TT et al
    2002/01/01
  • 備考:
    Species: Human, Rabbit, Application: IHC Paraffin-embedded, Sample type: Whole Tissue
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Masood R et al. Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops. Int. J. Cancer 2003 May;104(5):603-10
    Masood R et al
    2003/01/01
  • 備考:
    Application: IHC Fresh/Frozen,Western Blot, Sample Type: Cell Lysates,Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Giuliani N et al. Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis. Blood 2003 Jul;102(2):638-45
    Giuliani N et al
    2003/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    De S et al. Molecular pathway for cancer metastasis to bone. J. Biol. Chem. 2003 Oct;278(40):39044-50
    De S et al
    2003/01/01
  • 備考:
    human LNCaP, LNCaP-C4 2, PC3, and CWR22Rv1-H prostate cancer cell lines
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Kanda S et al. Fibroblast growth factor-2-mediated capillary morphogenesis of endothelial cells requires signals via Flt-1/vascular endothelial growth factor receptor-1: possible involvement of c-Akt. J. Biol. Chem. 2004 Feb;279(6):4007-16
    Kanda S et al
    2004/01/01
  • 備考:
    human umbilical vein endothelial cells and porcine aortic endothelial cells expressing human VEGF R2/KDR
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Usui T et al. VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. Invest. Ophthalmol. Vis. Sci. 2004 Feb;45(2):368-74
    Usui T et al
    2004/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Steiner H et al. An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6. Eur. J. Cancer 2004 May;40(7):1066-72
    Steiner H et al
    2004/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Eichler W et al. PEDF derived from glial Mテθ津つシller cells: a possible regulator of retinal angiogenesis. Exp. Cell Res. 2004 Sep;299(1):68-78
    Eichler W et al
    2004/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Szukiewicz D et al. Mast cell-derived VEGF and VEGF receptor type 1, 2, and 3 expression in human term trophoblast culture--influence of hypoxia. Inflamm. Res. 2005 Apr;54 Suppl 1:S82-3
    Szukiewicz D et al
    2005/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Asikainen TM et al. Activation of hypoxia-inducible factors in hyperoxia through prolyl 4-hydroxylase blockade in cells and explants of primate lung. Proc. Natl. Acad. Sci. U.S.A. 2005 Jul;102(29):10212-7
    Asikainen TM et al
    2005/01/01
  • 備考:
    Application: IHC Fresh,Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Garton AJ et al. OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models. Cancer Res. 2006 Jan;66(2):1015-24
    Garton AJ et al
    2006/01/01
  • 備考:
    Application: Immunoprecipitation, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Roberts N et al. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res. 2006 Mar;66(5):2650-7
    Roberts N et al
    2006/01/01
  • 備考:
    mouse tumor metastasis, lymph node, and lung
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Pyakurel P et al. Lymphatic and vascular origin of Kaposi&quot;s sarcoma spindle cells during tumor development. Int. J. Cancer 2006 Sep;119(6):1262-7
    Pyakurel P et al
    2006/01/01
  • 備考:
    Species: Human, Application: IHC Paraffin-embedded, Whole Tissue
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Albert DH et al. Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor. Mol. Cancer Ther. 2006 Apr;5(4):995-1006
    Albert DH et al
    2006/01/01
  • 備考:
    Application: Immunoprecipitation, Sample Type: Cell Lysates,Homogenized Tissue
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Asikainen TM et al. Enhancement of angiogenic effectors through hypoxia-inducible factor in preterm primate lung in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 2006 Oct;291(4):L588-95
    Asikainen TM et al
    2006/01/01
  • 備考:
    Species: Primate - Baboon, Application: Western Blot, Homogenized Tissue
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Cianfarani F et al. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am. J. Pathol. 2006 Oct;169(4):1167-82
    Cianfarani F et al
    2006/01/01
  • 備考:
    Species: Human, Application: Neutralization, Western Blot, Sample type: Whole Cells, Cell Lysates
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Argaw AT et al. IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J. Immunol. 2006 Oct;177(8):5574-84
    Argaw AT et al
    2006/01/01
  • 備考:
    Species: Human, Application: IHC Paraffin-embedded, Sample type: Whole Tissue
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Ferrari G et al. VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc. Natl. Acad. Sci. U.S.A. 2006 Nov;103(46):17260-5
    Ferrari G et al
    2006/01/01
  • 備考:
    Species: Human, Application: Western Blot, Sample type: Cell Lysates
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Goldman J et al. Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis. FASEB J. 2007 Apr;21(4):1003-12
    Goldman J et al
    2007/01/01
  • 備考:
    Application: Immunoprecipitation, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Hashimoto A et al. Analysis of vascular gene expression in arthritic synovium by laser-mediated microdissection. Arthritis Rheum. 2007 Apr;56(4):1094-105
    Hashimoto A et al
    2007/01/01
  • 備考:
    Species: Human, Application: IHC Frozen, Sample type: Whole Tissue
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Werner C et al. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. Diabetes 2007 Oct;56(10):2609-15
    Werner C et al
    2007/01/01
  • 備考:
    Species: Human, Application: Flow Cytometry, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Osol G et al. Placental growth factor is a potent vasodilator of rat and human resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 2008 Mar;294(3):H1381-7
    Osol G et al
    2008/01/01
  • 備考:
    Species: Rat, Application: Neutralization, Whole Tissue
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Mellberg S et al. Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis. FASEB J. 2009 May;23(5):1490-502
    Mellberg S et al
    2009/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Mittar S et al. VEGFR1 receptor tyrosine kinase localization to the Golgi apparatus is calcium-dependent. Exp. Cell Res. 2009 Mar;315(5):877-89
    Mittar S et al
    2009/01/01
  • 備考:
    Application: Immunoprecipitation, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Collino F et al. Epithelial-mesenchymal transition of ovarian tumor cells induces an angiogenic monocyte cell population. Exp. Cell Res. 2009 Oct;315(17):2982-94
    Collino F et al
    2009/01/01
  • 備考:
    Application: IHC Paraffin-embedded, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Ardi VC et al. Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway. J. Biol. Chem. 2009 Sep;284(38):25854-66
    Ardi VC et al
    2009/01/01
  • 備考:
    Application: Neutralization, Sample Type: collagen onplants
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Minami T et al. The Down syndrome critical region gene 1 short variant promoters direct vascular bed-specific gene expression during inflammation in mice. J. Clin. Invest. 2009 Aug;119(8):2257-70
    Minami T et al
    2009/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Albuquerque RJ et al. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat. Med. 2009 Sep;15(9):1023-30
    Albuquerque RJ et al
    2009/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Lee HS et al. Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis. Am. J. Respir. Crit. Care Med. 2009 Dec;180(11):1056-67
    Lee HS et al
    2009/01/01
  • 備考:
    Application: IHC Fresh/Frozen, Sample Type: Whole Tissue
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Lepp辰nen VM et al. Structural determinants of vascular endothelial growth factor-D receptor binding and specificity. Blood 2011 Feb;117(5):1507-15
    Lepp辰nen VM et al
    2011/01/01
  • 備考:
    Application: Immunoprecipitation, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Munaut C et al. Differential expression of Vegfr-2 and its soluble form in preeclampsia. PLoS ONE 2012;7(3):e33475
    Munaut C et al
    2012/01/01
  • 備考:
    Application: IHC Paraffin-embedded,Western Blot, Sample Type: Plasma,Whole Tissue
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Gourlaouen M et al. Essential role for endocytosis in the growth factor-stimulated activation of ERK1/2 in endothelial cells. J. Biol. Chem. 2013 Mar;288(11):7467-80
    Gourlaouen M et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: cell cultures
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Goldman O et al. KDR identifies a conserved human and murine hepatic progenitor and instructs early liver development. Cell Stem Cell 2013 Jun;12(6):748-60
    Goldman O et al
    2013/01/01
  • 備考:
    Application: IHC Fresh, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Kasza Z et al. MicroRNA-24 suppression of N-deacetylase/N-sulfotransferase-1 (NDST1) reduces endothelial cell responsiveness to vascular endothelial growth factor A (VEGFA). J. Biol. Chem. 2013 Sep;288(36):25956-63
    Kasza Z et al
    2013/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Orecchia A et al. Endothelial cell adhesion to soluble vascular endothelial growth factor receptor-1 triggers a cell dynamic and angiogenic phenotype. FASEB J. 2014 Feb;28(2):692-704
    Orecchia A et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Etulain J et al. Control of angiogenesis by galectins involves the release of platelet-derived proangiogenic factors. PLoS ONE 2014;9(4):e96402
    Etulain J et al
    2014/01/01
  • 備考:
    Application: Blocking, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Fearnley GW et al. VEGF-A isoforms differentially regulate ATF-2-dependent VCAM-1 gene expression and endothelial-leukocyte interactions. Mol. Biol. Cell 2014 Aug;25(16):2509-21
    Fearnley GW et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Fiorio Pla A et al. Differential sensitivity of prostate tumor derived endothelial cells to sorafenib and sunitinib. BMC Cancer 2014;14:939
    Fiorio Pla A et al
    2014/01/01
  • 備考:
    Application: Western Blot, Sample Type: Cell Lysate
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Shvartsman D et al. Sustained delivery of VEGF maintains innervation and promotes reperfusion in ischemic skeletal muscles via NGF/GDNF signaling. Mol. Ther. 2014 Jul;22(7):1243-53
    Shvartsman D et al
    2014/01/01
  • 備考:
    Application: Functional Assay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Basagiannis D et al. VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation through macropinocytosis. J. Cell. Sci. 2016 Nov;129(21):4091-4104
    Basagiannis D et al
    2016/01/01
  • 備考:
    Application: Neutralization, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Tiede C et al. Affimer proteins are versatile and renewable affinity reagents. Elife 2017 06;6
    Tiede C et al
    2017/01/01
  • 備考:
    Species: Human, Applications: WB
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Jin Y et al. Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling. Nat. Cell Biol. 2017 Jun;19(6):639-652
    Jin Y et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: IHC
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Heinolainen K et al. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling. Circ. Res. 2017 Apr;120(9):1414-1425
    Heinolainen K et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Volk-Draper LD et al. Lymphatic endothelial progenitors originate from plastic myeloid cells activated by toll-like receptor-4. PLoS ONE 2017;12(6):e0179257
    Volk-Draper LD et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Veschi V et al. Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant. Oncogene 2020 01;39(5):987-1003
    Veschi V et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Genet G et al. Endophilin-A2 dependent VEGFR2 endocytosis promotes sprouting angiogenesis. Nat Commun 2019 05;10(1):2350
    Genet G et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Fearnley GW et al. ATF-2 and Tpl2 regulation of endothelial cell cycle progression and apoptosis. Cell Signal 2020 02;66:109481
    Fearnley GW et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Dallinga MG et al. The Role of Heparan Sulfate and Neuropilin 2 in VEGFA Signaling in Human Endothelial Tip Cells and Non-Tip Cells during Angiogenesis In Vitro. Cells 2021 Apr;10(4)
    Dallinga MG et al
    2021/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Wei ST et al. Atypical chemokine receptor ACKR3/CXCR7 controls postnatal vasculogenesis and arterial specification by mesenchymal stem cells via Notch signaling. Cell Death Dis 2020 May;11(5):307
    Wei ST et al
    2020/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed